Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan

Eukaryotic Cell

Volumn 7, Issue 4, 2008, Pages 602-609

  Rodrigues, Marcio L ^a   Alvarez, Mauricio ^b   Fonseca, Fernanda L ^a   Casadevall, Arturo ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FILOBASIDIELLA NEOFORMANS; TRITICUM AESTIVUM;

CHITINASE; GLUCURONOXYLOMANNAN; POLYSACCHARIDE; TRYPSIN; WHEAT GERM AGGLUTININ;

ANIMAL; ARTICLE; CELL LINE; CELL WALL; CHEMISTRY; CRYPTOCOCCUS NEOFORMANS; CYTOLOGY; METABOLISM; MOUSE;

ANIMALS; CELL LINE; CELL WALL; CHITINASE; CRYPTOCOCCUS NEOFORMANS; MICE; POLYSACCHARIDES; TRYPSIN; WHEAT GERM AGGLUTININS;

EID: 42249087488     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00307-07     Document Type: Article

References (45)

1. Allen, A. K., A. Neuberger, and N. Sharon. 1973. The purification, composition and specificity of wheat-germ agglutinin. Biochem. J. 131:155-162.
2. Baker, L. G., C. A. Specht, M. J. Donlin, and J. K. Lodge. 2007. Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot. Cell 6:855-867.
3. Banks, I. R., C. A. Specht, M. J. Donlin, K. J. Gerik, S. M. Levitz, and J. K. Lodge. 2005. A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot. Cell 4:1902-1912.
4. Bose, I., A. J. Reese, J. J. Ory, G. Janbon, and T. L. Doering. 2003. A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot. Cell 2:655-663.
5. Casadevall, A., J. Mukherjee, and M. D. Scharff. 1992. Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J. Immunol. Methods 154: 27-35.
6. Casadevall, A., W. Cleare, M. Feldmesser, A. Glatman-Freedman, D. L. Goldman, T. R. Kozel, N. Lendvai, J. Mukherjee, L. A. Pirofski, J. Rivera, A. L. Rosas, M. D. Scharff, P. Valadon, K. Westin, and Z. Zhong. 1998. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob. Agents Chemother. 42:1437-1446.
7. Chen, C., and R. Contreras. 2004. The bud scar-based screening system for hunting human genes extending life span. Ann. N. Y. Acad. Sci. 1019:355-359.
8. Ciopraga, J., O. Gozia, R. Tudor, L. Brezuica, and R. J. Doyle. 1999. Fusarium sp. growth inhibition by wheat germ agglutinin. Biochim. Biophys. Acta 1428:424-432.
9. Cox, G. M., H. C. McDade, S. C. A. Chen, S. C. Tucker, M. Gottfredsson, L. C. Wright, T. C. Sorrell, S. D. Leidich, A. Casadevall, M. Ghannoum, and J. R. Perfect. 2001. Extracellular phospholipase is a virulence factor in experimental cryptococcosis. Mol. Microbiol. 39:166-175.
10. Cox, G. M., J. Mukherjee, G. T. Cole, A. Casadevall, and J. R. Perfect. 2000. Urease as a virulence factor in experimental cryptococcosis. Infect. Immun. 68:443-448.
11. Feldmesser, M., Y. Kress, and A. Casadevall. 2001. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147:2355-2365.
12. Foster, A. J., R. A. Bird, S. L. Kelly, K. Nishimura, D. Poyner, S. Taylor, and S. N. Smith. 2004. FITC-lectin avidity of Cryptococcus neoformans cell wall and capsular components. Mycologia 96:1-8.
13. Garcia-Rivera, J., Y. C. Chang, K. J. Kwon-Chung, and A. Casadevall. 2004. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot. Cell 3:385-392.
14. Hardy, M. R., and R. R. Townsend. 1994. High-pH anion-exchange chromatography of glycoprotein-derived carbohydrates. Methods Enzymol. 230:208-225.
15. Janbon, G. 2004. Cryptococcus neoformans capsule biosynthesis and regulation. FEMS Yeast Res. 4:765-771.
16. Jong, A., C. H. Wu, H. M. Chen, F. Luo, K. J. Kwon-Chung, Y. C. Chang, C. W. Lamunyon, A. Plaas, and S. H. Huang. 2007. Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot. Cell 6:1486-1496.
17. Kneipp, L. F., A. F. Andrade, W. de Souza, J. Angluster, C. S. Alviano, and L. R. Travassos. 1998. Trichomonas vaginalis and Tritrichomonas foetus: expression of chitin at the cell surface. Exp. Parasitol. 89:195-204.
18. Kozel, T. R., G. S. Pfrommer, A. S. Guerlain, B. A. Highison, and G. J. Highison. 1988. Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev. Infect. Dis. 10:S436-S439.
19. Lengeler, K. B., R. C. Davidson, C. D'souza, T. Harashima, W. C. Shen, P. Wang, X. Pan, M. Waugh, and J. Heitman. 2000. Signal transduction cascades regulating fungal development and virulence. Microbiol. Mol. Biol. Rev. 64:746-785.
20. Levitz, S. M., and C. A. Specht. 2006. The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res. 6:513-524.
21. Maxson, M. E., E. Dadachova, A. Casadevall, and O. Zaragoza. 2007. Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule. Eukaryot. Cell 6:95-109.
22. McClelland, E. E., P. Bernhardt, and A. Casadevall. 2006. Estimating the relative contributions of virulence factors for pathogenic microbes. Infect. Immun. 74:1500-1504.
23. McFadden, D. C., M. De Jesus, and A. Casadevall. 2006. The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction. J. Biol. Chem. 281:1868-1875.
24. McFadden, D., O. Zaragoza, and A. Casadevall. 2006. The capsular dynamics of Cryptococcus neoformans. Trends Microbiol. 14:497-505.
25. Monari, C., F. Bistoni, and A. Vecchiarelli. 2006. Glucuronoxylomannan exhibits potent immunosuppressive properties. FEMS Yeast Res. 6:537-542.
26. Monsigny, M., C. Sene, A. Obrenovitch, A. C. Roche, F. Delmotte, and E. Boschetti. 1979. Properties of succinylated wheat-germ agglutinin. Eur. J. Biochem. 98:39-45.
27. Moyrand, F., T. Fontaine, and G. Janbon. 2007. Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol. Microbiol. 64:771-781.
28. Nimrichter, L., M. L. Rodrigues, E. G. Rodrigues, and L. R. Travassos. 2005. The multitude of targets for the immune system and drug therapy in the fungal cell wall. Microbes Infect. 7:789-798.
29. Nimrichter, L., S. Frases, L. P. Cinelli, N. B. Viana, A. Nakouzi, L. R. Travassos, A. Casadevall, and M. L. Rodrigues. 2007. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot. Cell 6:1400-1410.
30. Pericolini, E., E. Cenci, C. Monari, M. De Jesus, F. Bistoni, A. Casadevall, and A. Vecchiarelli. 2006. Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8. Cell. Microbiol. 8:267-275.
31. Peumans, W. J., M. De Ley, H. M. Stinissen, and W. F. Broekaert. 1985. Isolation and partial characterization of a new lectin from seeds of the greater celandine (Chelidonium majus). Plant Physiol. 78:379-383.
32. Privat, J. P., F. Delmotte, G. Mialonier, P. Bouchard, and M. Monsigny. 1974. Fluorescence studies of saccharide binding to wheat-germ agglutinin (lectin). Eur. J. Biochem. 47:5-14.
33. Reese, A. J., and T. L. Doering. 2003. Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol. Microbiol. 50:1401-1409.
34. Reese, A. J., A. Yoneda, J. A. Breger, A. Beauvais, H. Liu, C. L. Griffith, I. Bose, M. J. Kim, C. Skau, S. Yang, J. A. Sefko, M. Osumi, J. P. Latge, E. Mylonakis, and T. L. Doering. 2007. Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence. Mol. Microbiol. 63:1385-1398.
35. Rodrigues, M. L., L. Nimrichter, D. O. Oliveira, S. Frases, K. Miranda, O. Zaragoza, M. Alvarez, A. Nakouzi, M. Feldmesser, and A. Casadevall. 2007. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot. Cell 6:48-59.
36. Rodrigues, M. L., L. R. Travassos, K. R. Miranda, A. J. Franzen, S. Rozental, W. de Souza, C. S. Alviano, and E. Barreto-Bergter. 2000. Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. Infect. Immun. 68:7049-7060.
37. Rodrigues, M. L., S. Rozental, J. N. N. Couceiro, J. Angluster, C. S. Alviano, and L. R. Travassos. 1997. Identification of N-acetylneuraminic acid and its 9-O-acetylated derivative on the cell surface of Cryptococcus neoformans: influence on fungal phagocytosis. Infect. Immun. 65:4937-4942.
38. Senstad, C., and B. Mattiasson. 1989. Purification of wheat germ agglutinin using affinity flocculation with chitosan and a subsequent centrifugation or flotation step. Biotechnol. Bioeng. 34:387-393.
39. Toda, N., A. Doi, A. Jimbo, I. Matsumoto, and N. Seno. 1981. Interaction of sulfated glycosaminoglycans with lectins. J. Biol. Chem. 256:5345-5349.
40. Walton, F. J., A. Idnurm, and J. Heitman. 2005. Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans. Mol. Microbiol. 57:1381-1396.
41. Waters, L., and M. Nelson. 2005. Cryptococcal disease and HIV infection. Expert Opin. Pharmacother. 6:2633-2644.
42. Williamson, P. R. 1997. Laccase and melanin in the pathogenesis of Cryptococcus neoformans. Front. Biosci. 2:e99-e107.
43. Yoneda, A., and T. L. Doering. 2006. A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis. Mol. Biol. Cell 17: 5131-5140.
44. Zaragoza, O., A. Telzak, R. A. Bryan, E. Dadachova, and A. Casadevall. 2006. The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding. Mol. Microbiol. 59:67-83.
45. Zaragoza, O., E. E. McClelland, A. Telzak, and A. Casadevall. 2006. Equatorial ring-like channels in the Cryptococcus neoformans polysaccharide capsule. FEMS Yeast Res. 6:662-666.